Scholar Rock Holding Corp (NASDAQ:SRRK) — Market Cap & Net Worth
Market Cap & Net Worth: Scholar Rock Holding Corp (SRRK)
Scholar Rock Holding Corp (NASDAQ:SRRK) has a market capitalization of $4.69 Billion ($4.69 Billion) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #3750 globally and #1259 in its home market, demonstrating a -2.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Scholar Rock Holding Corp's stock price $46.37 by its total outstanding shares 102007457 (102.01 Million). Analyse SRRK cash flow conversion to see how efficiently the company converts income to cash.
Scholar Rock Holding Corp Market Cap History: 2018 to 2026
Scholar Rock Holding Corp's market capitalization history from 2018 to 2026. Data shows growth from $2.34 Billion to $4.73 Billion (14.79% CAGR).
Index Memberships
Scholar Rock Holding Corp is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.19% | #81 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.01% | #407 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.67 Trillion | 0.28% | #55 of 263 |
Weight: Scholar Rock Holding Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Scholar Rock Holding Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Scholar Rock Holding Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
27.81x
Scholar Rock Holding Corp's market cap is 27.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $1.34 Billion | $20.49 Million | -$49.70 Million | 65.61x | N/A |
| 2020 | $4.95 Billion | $15.40 Million | -$84.99 Million | 321.39x | N/A |
| 2021 | $2.53 Billion | $18.82 Million | -$131.80 Million | 134.67x | N/A |
| 2022 | $923.17 Million | $33.19 Million | -$131.65 Million | 27.81x | N/A |
Competitor Companies of SRRK by Market Capitalization
Companies near Scholar Rock Holding Corp in the global market cap rankings as of May 4, 2026.
Key companies related to Scholar Rock Holding Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Scholar Rock Holding Corp Historical Marketcap From 2018 to 2026
Between 2018 and today, Scholar Rock Holding Corp's market cap moved from $2.34 Billion to $ 4.73 Billion, with a yearly change of 14.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $4.73 Billion | +5.27% |
| 2025 | $4.49 Billion | +1.92% |
| 2024 | $4.41 Billion | +129.89% |
| 2023 | $1.92 Billion | +107.73% |
| 2022 | $923.17 Million | -63.57% |
| 2021 | $2.53 Billion | -48.82% |
| 2020 | $4.95 Billion | +268.21% |
| 2019 | $1.34 Billion | -42.62% |
| 2018 | $2.34 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Scholar Rock Holding Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.69 Billion USD |
| MoneyControl | $4.69 Billion USD |
| MarketWatch | $4.69 Billion USD |
| marketcap.company | $4.69 Billion USD |
| Reuters | $4.69 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Scholar Rock Holding Corp
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to deve… Read more